Article

Bioactive Compounds from Abelmoschus manihot L. Alleviate the Progression of Multiple…

OncoTargets and Therapy · 2020 · Hou J, Qian J, Li Z, Gong A, Zhong S, Qiao L, Qian S, Zhang Y, Dou R, Li R, Yang Y, Gu C

Key facts

Title Bioactive Compounds from Abelmoschus manihot L. Alleviate the Progression of Multiple Myeloma in Mouse Model and Improve Bone Marrow Microenvironment
First author Hou J, Qian J, Li Z, Gong A, Zhong S, Qiao L, Qian S, Zhang Y, Dou R, Li R, Yang Y, Gu C
Journal OncoTargets and Therapy
Published Jan 31, 2020
DOI 10.2147/OTT.S235944
Devices mentioned 210001, 210028, BK110039, K080874, K103302, K810863, K973350, K990827
Product codes mentioned CIX, DBM, JLX, KQP, NDS, PCA, KHS, KIP, KIT, NJT, OOI, PFF and 2 more

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature